
CDT Equity Inc.
CDTHealthcare|Biotechnology|US
$1.31
+0.46 (+54.85%)
Graham Number
$3161.02
Cash / Share
$654.14
Financing Filings (last 12 months)
12
Shelf registrations / offering prospectuses — latest Nov 4, 2026 (424B3). Possible dilution.
Upcoming Data Readouts (0)
No upcoming completion dates found in active trials.
Recent Press Releases
CDT Equity Welcomes U.S. Regulatory Development Supporting Expanded Access to Compounded Peptides
Oct 30, 2026 · GlobeNewsWire
CDT Partners with Manoira to Explore Enhancing Animal Health Products Ahead of Launch
Oct 27, 2026 · GlobeNewsWire
CDT Highlights Sarborg's Solid-Form Patent Filing on a First-in-Class Respiratory Asset
Oct 14, 2026 · GlobeNewsWire
CDT Highlights Sarborg's Expanding Quantum Computing IP Portfolio and Application to Drug Discovery
Sep 29, 2026 · GlobeNewsWire
CDT Equity Inc. Announces Reverse Stock Split
Sep 25, 2026 · GlobeNewsWire
CDT Partners with QIMA Life Sciences to Evaluate Novel Tapinarof Combinations in Psoriasis and Vitiligo
Sep 18, 2026 · GlobeNewsWire
CDT Highlights Sarborg's Application of Signature Intelligence and Quantum Computing Models to Mental Health
Sep 10, 2026 · GlobeNewsWire
CDT Provides Capital Update and Confirms No Nasdaq Deficiencies
Sep 2, 2026 · GlobeNewsWire
CDT Appoints Co-Founder James Bligh as Chief Executive Officer to Lead Next Phase of Growth
Sep 1, 2026 · GlobeNewsWire
CDT Validates Enhanced Solid-Form Properties Within Its IP Portfolio
Aug 28, 2026 · GlobeNewsWire
SEC Filings (140)
Last two years from EDGAR. Insider Form 4s are on the Ownership tab.
| Filed | Form | What it is | Links |
|---|---|---|---|
| Nov 6, 2026 | SC 13D/A | Activist / 5%+ stake | DocumentIndex |
| Nov 4, 2026 | 424B3 | Offering prospectus | DocumentIndex |
| Nov 4, 2026 | 8-K | Material event | DocumentIndex |
| Nov 3, 2026 | 424B3 | Offering prospectus | DocumentIndex |
| Oct 27, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Oct 27, 2026 | DEF 14A | Proxy / shareholder vote | DocumentIndex |
| Oct 27, 2026 | SC 13D/A | Activist / 5%+ stake | DocumentIndex |
| Oct 27, 2026 | 8-K | Material event | DocumentIndex |
| Oct 16, 2026 | PRE 14A | Proxy / shareholder vote | DocumentIndex |
| Oct 13, 2026 | 424B3 | Offering prospectus | DocumentIndex |
| Oct 13, 2026 | 8-K | Material event | DocumentIndex |
| Oct 8, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Oct 7, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Oct 7, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Oct 7, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Oct 2, 2026 | 424B3 | Offering prospectus | DocumentIndex |
| Sep 25, 2026 | 8-K | Material event | DocumentIndex |
| Sep 18, 2026 | 424B3 | Offering prospectus | DocumentIndex |
| Sep 18, 2026 | 8-K | Material event | DocumentIndex |
| Sep 18, 2026 | 424B3 | Offering prospectus | DocumentIndex |
| Sep 17, 2026 | EFFECT | DocumentIndex | |
| Sep 9, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Sep 8, 2026 | S-1 | IPO / offering registration | DocumentIndex |
| Sep 4, 2026 | 8-K | Material event | DocumentIndex |
| Sep 2, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Sep 2, 2026 | SC 13D/A | Activist / 5%+ stake | DocumentIndex |
| Sep 1, 2026 | 8-K | Material event | DocumentIndex |
| Sep 1, 2026 | 8-K | Material event | DocumentIndex |
| Aug 21, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Aug 21, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Aug 21, 2026 | 8-K/A | Material event | DocumentIndex |
| Aug 21, 2026 | 8-K/A | Material event | DocumentIndex |
| Aug 12, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Aug 12, 2026 | DEFA14A | Proxy / shareholder vote | DocumentIndex |
| Aug 11, 2026 | ARS | Annual report to holders | DocumentIndex |
| Aug 11, 2026 | DEF 14A | Proxy / shareholder vote | DocumentIndex |
| Aug 6, 2026 | 8-K | Material event | DocumentIndex |
| Aug 3, 2026 | 8-K/A | Material event | DocumentIndex |
| Jul 31, 2026 | PRE 14A | Proxy / shareholder vote | DocumentIndex |
| Jul 31, 2026 | 8-K | Material event | DocumentIndex |